CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01658917
NCT01658917N/ACompleted

Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets

National Cancer Institute (NCI)·observational·Posted Aug 7, 2012·Updated May 30, 2023

In Brief

An observational study for Gastrointestinal Cancer and 3 related conditions. Completed, enrolled 133 participants across 1 site.

Detailed Summary

Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow tissue samples obtained during the protocol screening process to be used for future and ongoing research in the NCI Surgery Branch Eligibility: Patients must meet the minimum eligibility criteria for an NCI surgery Branch Treatment Protocol Design Patients will undergo testing and evaluations as required by the appropriate NCI Surgery Branch Treatment protocol

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 7, 2012
Enrollment StartJul 24, 2012
Primary CompletionJun 1, 2017
Study CompletionOct 23, 2017
TodayJul 1, 2026
Enrollment to primary: 4.9 yearsPosted 13.9 years ago